Literature DB >> 7942444

Cardiomyopathy and angiopathy in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes.

W Sato1, M Tanaka, S Sugiyama, T Nemoto, K Harada, Y Miura, Y Kobayashi, A Goto, G Takada, T Ozawa.   

Abstract

In four patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS) in which mutated mitochondrial deoxyribonucleic acid was seen, hypertrophic cardiomyopathy and angiopathy was demonstrated by echocardiography, dipyridamole stress scintigraphy, and cardiac catheterization. On stress scintigraphy with dipyridamole, three patients showed hypoperfusion in the early image and a "filling-in" pattern in the late image. However, coronary angiography did not demonstrate narrowing of the large vessels in these patients. Light and electron microscopy of endomyocardial biopsy specimens indicated abnormal mitochondria, with marked increase in the number and size of mitochondria in endothelium. Modified Gomori's trichrome staining in biopsied endomyocardial specimens revealed a red-purple deposit similar in appearance of the ragged-red fibers in skeletal muscle, a characteristic finding of mitochondrial disease. Deterioration of complex I in the mitochondrial electron transfer system, which is widely observed in various mitochondrial diseases, appeared in biopsied skeletal muscle of our patients, indicating deficiency of some subunits of complex I. These results indicate that mitochondrial diseases such as MELAS show not only cardiomyopathy but also angiopathy. We speculate that proliferation of mitochondria leads to narrowing of the lumen of arterioles, which might be responsible for the ischemic findings observed scintigraphically.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7942444     DOI: 10.1016/0002-8703(94)90272-0

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  8 in total

1.  [Characteristics of anesthesia in patients with MELAS syndrome: Case report of anesthesia in video-assisted thoracoscopy].

Authors:  A Haas; F Wappler
Journal:  Anaesthesist       Date:  2015-08-28       Impact factor: 1.041

Review 2.  MELAS syndrome and cardiomyopathy: linking mitochondrial function to heart failure pathogenesis.

Authors:  Ying-Han R Hsu; Haran Yogasundaram; Nirmal Parajuli; Lucas Valtuille; Consolato Sergi; Gavin Y Oudit
Journal:  Heart Fail Rev       Date:  2016-01       Impact factor: 4.214

3.  Cardiovascular Complications of Neuromuscular Disorders.

Authors:  Bhavesh Sachdev; Perry M. Elliott; William J. McKenna
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-04

4.  A follow up study of myocardial involvement in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS).

Authors:  Y Okajima; Y Tanabe; M Takayanagi; H Aotsuka
Journal:  Heart       Date:  1998-09       Impact factor: 5.994

5.  Cardiac scintigraphic findings of mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: A case report.

Authors:  Shinro Matsuo; Kenichi Nakajima; Seigo Kinuya; Yuichi Sato; Naoya Matsumoto; Minoru Horie
Journal:  Exp Clin Cardiol       Date:  2008

6.  Pulmonary artery hypertension in a child with MELAS due to a point mutation of the mitochondrial tRNA((Leu)) gene (m.3243A>G).

Authors:  D M Sproule; J Dyme; J Coku; D de Vinck; E Rosenzweig; W K Chung; D C De Vivo
Journal:  J Inherit Metab Dis       Date:  2008-01-07       Impact factor: 4.982

7.  Characteristic cardiac phenotypes are detected by cardiovascular magnetic resonance in patients with different clinical phenotypes and genotypes of mitochondrial myopathy.

Authors:  Anca Florian; Anna Ludwig; Bianca Stubbe-Dräger; Matthias Boentert; Peter Young; Johannes Waltenberger; Sabine Rösch; Udo Sechtem; Ali Yilmaz
Journal:  J Cardiovasc Magn Reson       Date:  2015-05-22       Impact factor: 5.364

8.  Cardiac abnormalities in patients with mitochondrial DNA mutation 3243A>G.

Authors:  Kirsi Majamaa-Voltti; Keijo Peuhkurinen; Marja-Leena Kortelainen; Ilmo E Hassinen; Kari Majamaa
Journal:  BMC Cardiovasc Disord       Date:  2002-08-01       Impact factor: 2.298

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.